Fri, Dec 20, 2024
Senores Pharmaceuticals launches IPO to drive global expansion, fund sterile manufacturing, and strengthen its footprint in critical care and regulated markets.
More >
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.